PD-012Early tumour shrinkage (ETS) and its impact on tumour-related symptoms in patients with previously untreated RAS wild-type metastatic colorectal cancer (mCRC): A retrospective analysis of three panitumumab studies. (20th June 2018) - Taieb, J; Geissler, M; Rivera, F; Karthaus, M; Wilson, R; Loupakis, F; Price, T; Tracy, M; Burdon, P; Peeters, M